Enviva Analyst Ratings
Enviva Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/03/2023 | 29.87% | RBC Capital | → $10 | Reiterates | Sector Perform → Sector Perform |
| 07/11/2023 | 159.74% | Citigroup | $32 → $20 | Maintains | Buy |
| 05/15/2023 | 29.87% | RBC Capital | $32 → $10 | Maintains | Sector Perform |
| 05/05/2023 | 224.68% | Raymond James | $55 → $25 | Maintains | Strong Buy |
| 05/04/2023 | 29.87% | Truist Securities | $40 → $10 | Downgrades | Buy → Sell |
| 04/05/2023 | 315.58% | Citigroup | $62 → $32 | Maintains | Buy |
| 04/05/2023 | 614.29% | Raymond James | $65 → $55 | Maintains | Strong Buy |
| 04/04/2023 | 419.48% | Truist Securities | $70 → $40 | Maintains | Buy |
| 04/04/2023 | 315.58% | Citigroup | $62 → $32 | Maintains | Buy |
| 03/03/2023 | 471.43% | JP Morgan | $61 → $44 | Maintains | Neutral |
| 03/02/2023 | 744.16% | Raymond James | $80 → $65 | Maintains | Strong Buy |
| 02/01/2023 | 809.09% | Truist Securities | $80 → $70 | Maintains | Buy |
| 11/29/2022 | 718.18% | RBC Capital | $76 → $63 | Maintains | Sector Perform |
| 10/20/2022 | 679.22% | JP Morgan | $66 → $60 | Maintains | Neutral |
| 10/18/2022 | 938.96% | Raymond James | → $80 | Upgrades | Outperform → Strong Buy |
| 10/14/2022 | 705.19% | Citigroup | $79 → $62 | Upgrades | Neutral → Buy |
| 09/15/2022 | 938.96% | Raymond James | → $80 | Upgrades | Market Perform → Outperform |
| 08/19/2022 | 887.01% | RBC Capital | $78 → $76 | Downgrades | Outperform → Sector Perform |
| 07/20/2022 | 822.08% | JP Morgan | $70 → $71 | Maintains | Neutral |
| 05/13/2022 | 912.99% | RBC Capital | $85 → $78 | Maintains | Outperform |
| 04/19/2022 | 900% | JP Morgan | $76 → $77 | Maintains | Neutral |
| 04/05/2022 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 03/29/2022 | 1198.7% | Truist Securities | → $100 | Initiates Coverage On | → Buy |
| 03/07/2022 | 1003.9% | RBC Capital | $78 → $85 | Maintains | Outperform |
| 03/02/2022 | 887.01% | JP Morgan | $70 → $76 | Maintains | Neutral |
| 01/04/2022 | 900% | Raymond James | $75 → $77 | Maintains | Outperform |
| 12/09/2021 | 900% | JP Morgan | → $77 | Downgrades | Overweight → Neutral |
| 11/05/2021 | 874.03% | Raymond James | $57 → $75 | Maintains | Outperform |
| 10/18/2021 | 938.96% | Barclays | $67 → $80 | Maintains | Overweight |
| 10/18/2021 | 874.03% | RBC Capital | $60 → $75 | Maintains | Outperform |
| 10/05/2021 | 640.26% | Raymond James | → $57 | Downgrades | Strong Buy → Outperform |
| 09/07/2021 | 718.18% | JP Morgan | → $63 | Initiates Coverage On | → Overweight |
| 09/02/2021 | 601.3% | Goldman Sachs | → $54 | Initiates Coverage On | → Neutral |
| 06/07/2021 | 744.16% | Barclays | $64 → $65 | Maintains | Overweight |
| 02/25/2021 | 640.26% | Raymond James | $52 → $57 | Maintains | Strong Buy |
| 01/08/2021 | 575.32% | Raymond James | $48 → $52 | Maintains | Strong Buy |
| 11/05/2020 | 523.38% | Raymond James | $44 → $48 | Maintains | Strong Buy |
| 10/08/2020 | 471.43% | Raymond James | $42 → $44 | Maintains | Strong Buy |
| 06/24/2020 | 445.45% | Raymond James | $38 → $42 | Maintains | Strong Buy |
| 04/30/2020 | 393.51% | Raymond James | $36 → $38 | Maintains | Strong Buy |
| 04/24/2020 | 354.55% | Citigroup | $40 → $35 | Maintains | Neutral |
| 03/18/2020 | 419.48% | Raymond James | → $40 | Upgrades | Outperform → Strong Buy |
| 02/13/2020 | 419.48% | Citigroup | $34 → $40 | Downgrades | Buy → Neutral |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 10/03/2023 | 29.87% | 加拿大皇家銀行資本 | →$10 | 重申 | 扇區表現→扇區表現 |
| 07/11/2023 | 159.74% | 花旗集團 | $32→$20 | 維護 | 買 |
| 2023年05月15日 | 29.87% | 加拿大皇家銀行資本 | $32→$10 | 維護 | 行業表現 |
| 05/05/2023 | 224.68% | 雷蒙德·詹姆斯 | $55→$25 | 維護 | 強勢購買 |
| 05/04/2023 | 29.87% | Truist證券 | $40→$10 | 評級下調 | Buy→Sell |
| 04/05/2023 | 315.58% | 花旗集團 | $62→$32 | 維護 | 買 |
| 04/05/2023 | 614.29% | 雷蒙德·詹姆斯 | $65→$55 | 維護 | 強勢購買 |
| 04/04/2023 | 419.48% | Truist證券 | $70→$40 | 維護 | 買 |
| 04/04/2023 | 315.58% | 花旗集團 | $62→$32 | 維護 | 買 |
| 03/03/2023 | 471.43% | 摩根大通 | $61→$44 | 維護 | 中性 |
| 03/02/2023 | 744.16% | 雷蒙德·詹姆斯 | $80→$65 | 維護 | 強勢購買 |
| 02/01/2023 | 809.09% | Truist證券 | $80→$70 | 維護 | 買 |
| 2022年11月29日 | 718.18% | 加拿大皇家銀行資本 | $76→$63 | 維護 | 行業表現 |
| 10/20/2022 | 679.22% | 摩根大通 | $66→$60 | 維護 | 中性 |
| 10/18/2022 | 938.96% | 雷蒙德·詹姆斯 | →$80 | 升級 | 跑贏→強勢買入 |
| 10/14/2022 | 705.19% | 花旗集團 | $79→$62 | 升級 | 中性→購買 |
| 09/15/2022 | 938.96% | 雷蒙德·詹姆斯 | →$80 | 升級 | 市場表現優於→ |
| 2022年08月19日 | 887.01% | 加拿大皇家銀行資本 | $78→$76 | 評級下調 | 跑贏→板塊表現 |
| 07/20/2022 | 822.08% | 摩根大通 | $70→$71 | 維護 | 中性 |
| 2022年05月13日 | 912.99% | 加拿大皇家銀行資本 | $85→$78 | 維護 | 跑贏大盤 |
| 04/19/2022 | 900% | 摩根大通 | $76→$77 | 維護 | 中性 |
| 04/05/2022 | - | 雷蒙德·詹姆斯 | 評級下調 | 跑贏→市場表現 | |
| 03/29/2022 | 1198.7% | Truist證券 | →$100 | 開始承保 | →購買 |
| 03/07/2022 | 1003.9% | 加拿大皇家銀行資本 | $78→$85 | 維護 | 跑贏大盤 |
| 03/02/2022 | 887.01% | 摩根大通 | $70→$76 | 維護 | 中性 |
| 01/04/2022 | 900% | 雷蒙德·詹姆斯 | $75→$77 | 維護 | 跑贏大盤 |
| 12/09/2021 | 900% | 摩根大通 | →$77 | 評級下調 | 超重→中性 |
| 2021年11月05日 | 874.03% | 雷蒙德·詹姆斯 | $57→$75 | 維護 | 跑贏大盤 |
| 10/18/2021 | 938.96% | 巴克萊 | $67→$80 | 維護 | 超重 |
| 10/18/2021 | 874.03% | 加拿大皇家銀行資本 | $60→$75 | 維護 | 跑贏大盤 |
| 10/05/2021 | 640.26% | 雷蒙德·詹姆斯 | →$57 | 評級下調 | 強勢買入→跑贏大盤 |
| 09/07/2021 | 718.18% | 摩根大通 | →$63 | 開始承保 | →超重 |
| 09/02/2021 | 601.3% | 高盛 | →$54 | 開始承保 | →中性 |
| 06/07/2021 | 744.16% | 巴克萊 | $64→$65 | 維護 | 超重 |
| 02/25/2021 | 640.26% | 雷蒙德·詹姆斯 | $52→$57 | 維護 | 強勢購買 |
| 01/08/2021 | 575.32% | 雷蒙德·詹姆斯 | $48→$52 | 維護 | 強勢購買 |
| 11/05/2020 | 523.38% | 雷蒙德·詹姆斯 | $44→$48 | 維護 | 強勢購買 |
| 10/08/2020 | 471.43% | 雷蒙德·詹姆斯 | $42→$44 | 維護 | 強勢購買 |
| 06/24/2020 | 445.45% | 雷蒙德·詹姆斯 | $38→$42 | 維護 | 強勢購買 |
| 04/30/2020 | 393.51% | 雷蒙德·詹姆斯 | $36→$38 | 維護 | 強勢購買 |
| 04/24/2020 | 354.55% | 花旗集團 | $40→$35 | 維護 | 中性 |
| 03/18/2020 | 419.48% | 雷蒙德·詹姆斯 | →$40 | 升級 | 跑贏→強勢買入 |
| 02/13/2020 | 419.48% | 花旗集團 | $34→$40 | 評級下調 | 購買→中性 |
What is the target price for Enviva (EVA)?
英傑華(Eviva)的目標價是多少？
The latest price target for Enviva (NYSE: EVA) was reported by RBC Capital on October 3, 2023. The analyst firm set a price target for $10.00 expecting EVA to rise to within 12 months (a possible 29.87% upside). 16 analyst firms have reported ratings in the last year.
加拿大皇家銀行資本於2023年10月3日報道了Enviva(紐約證券交易所代碼：EVA)的最新目標價。這家分析公司將目標價定為10.00美元，預計EVA將在12個月內升至(可能上漲29.87%)。過去一年，有16家分析公司公佈了評級。
What is the most recent analyst rating for Enviva (EVA)?
分析師對Eviva的最新評級是多少？
The latest analyst rating for Enviva (NYSE: EVA) was provided by RBC Capital, and Enviva reiterated their sector perform rating.
加拿大皇家銀行資本提供了對Enviva(紐約證券交易所股票代碼：EVA)的最新分析師評級，Enviva重申了其行業表現評級。
When is the next analyst rating going to be posted or updated for Enviva (EVA)?
Enviva(EVA)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Enviva, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Enviva was filed on October 3, 2023 so you should expect the next rating to be made available sometime around October 3, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Enviva的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Enviva的上一次評級是在2023年10月3日提交的，所以你應該預計下一次評級將在2024年10月3日左右的某個時候提供。
Is the Analyst Rating Enviva (EVA) correct?
分析師對Enviva(EVA)的評級正確嗎？
While ratings are subjective and will change, the latest Enviva (EVA) rating was a reiterated with a price target of $0.00 to $10.00. The current price Enviva (EVA) is trading at is $7.70, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Enviva(EVA)評級被重申，目標價在0.00美元至10.00美元之間。英傑華(Enviva)目前的股價為7.70美元，在分析師的預測範圍內。